Alerts will be sent to your verified email
Verify Email
KABRADG
|
Kabra Drugs
|
Zenith Health Care
|
Ishita Drugs & Inds.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
65.41 % | 4.69 % | 8.34 % |
|
5yr average Equity Multiplier
|
-11.28 | 1.34 | 1.24 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.59 | 1.36 |
|
5yr Avg Net Profit Margin
|
0.0 | 2.26 % | 5.01 % |
|
Price to Book
|
7.92 | 3.43 | 2.24 |
|
P/E
|
0.0 | 0.0 | 27.03 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 77.41 Days | 40.65 Days |
|
Inventory Days
|
0.0 | 70.5 Days | 24.87 Days |
|
Days Receivable
|
0.0 | 54.46 Days | 30.03 Days |
|
Days Payable
|
0.0 | 55.38 Days | 48.29 Days |
|
5yr Average Interest Coverage Ratio
|
-836.53 | 47.8 | 25.37 |
|
5yr Avg ROCE
|
64.57 % | 6.61 % | 11.35 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 2.14 % | 6.35 % |
|
5 yr average Debt to Equity
|
-6.16 | 0.0 | 0.03 |
|
5yr CAGR Net Profit
|
65.28 % | -18.9 % | 6.4 % |
|
5yr Average Return on Assets
|
-21.32 % | 3.55 % | 6.76 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 28.74 % | 49.91 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.6 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kabra Drugs
|
Zenith Health Care
|
Ishita Drugs & Inds.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|